Disc up another 5.4% last night on impressive volume to a market cap of $2.5 Billion AUD. That is more than three times the valuation of CUV. CUV has the FDA, EMA drug and the absolute monopoly on EPP and great cash and profits with a Phase 3 into blockbuster Vitiligo. Loss making Disc just hoping to one day in many years to achieve approval in EPP and enter that market. I think it's fair to say shorters have had a big impact here at CUV as ASIC daily data shows and some effort needs to be made to protect shareholder interests right now via a share buyback. Disc is also so much better at attracting investor interest than at CUV and they need to lift their game a lot in that area - after all the newsletter stated it only took one institution buying a lot of shares in one month to take the CUV price over $40.
All IMO DYOR
Disc up another 5.4% last night on impressive volume to a market...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.57 |
Change
0.170(1.10%) |
Mkt cap ! $780.1M | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.63 | $15.25 | $751.5K | 48.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 165 | $15.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.59 | 106 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.57 |
Change
0.170 ( 0.95 %) |
||||
| Open | High | Low | Volume | ||
| $15.39 | $15.63 | $15.33 | 8111 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| CUV (ASX) Chart |